Effects of chronic beta-receptor blocker treatment on cardiac high-energy phosphate metabolism in heart failure

Effects of chronic beta-receptor blocker treatment on cardiac high-energy phosphate metabolism in heart failure

In heart failure, chronic therapy with beta-receptor blocking agents improves cardiac performance and prolongs survival, but the exact mechanisms whereby these compounds exert such beneficial effects remain unclear. One hypothesis is that beta-blockers improve the energetic balance of the heart and...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Neubauer, S
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2000

Míreanna comhchosúla

Beta-blockers in cardiac failure.
de réir: Neubauer, G, et al.
Foilsithe / Cruthaithe: (1994)

Beta-blockers in chronic heart failure in elderly patient
de réir: Alberto De Bernardi
Foilsithe / Cruthaithe: (2009-06-01)

OPTIMAL USE OF BETA-BLOCKERS IN CASE OF CHRONIC HEART FAILURE
de réir: N. A. Shostak, et al.
Foilsithe / Cruthaithe: (2016-09-01)

Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
de réir: Stephan von Haehling, et al.
Foilsithe / Cruthaithe: (2009-07-01)

Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats
de réir: Igor Belenichev, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Influence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularization
de réir: Irina V. Askari, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
de réir: Baoshan Liu, et al.
Foilsithe / Cruthaithe: (2023-02-01)

β3blockers in treatment of chronic heart failure
de réir: M. A. Gurevich
Foilsithe / Cruthaithe: (2004-04-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
de réir: A. A. Aleksandrov, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Outcomes of beta-blocker pharmacotherapy in patients with heart failure
de réir: Maletin Sanja D., et al.
Foilsithe / Cruthaithe: (2024-01-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
de réir: Kazufumi Nakamura, et al.
Foilsithe / Cruthaithe: (2011-08-01)

NEW ADVANCES IN BETA-BLOCKER THERAPY IN HEART FAILURE
de réir: Vincenzo eBarrese, et al.
Foilsithe / Cruthaithe: (2013-11-01)

CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
de réir: S. R. Giljarevskiy, et al.
Foilsithe / Cruthaithe: (2016-01-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
de réir: I. V. Vologdina
Foilsithe / Cruthaithe: (2015-12-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
de réir: I. V. Vologdina
Foilsithe / Cruthaithe: (2015-12-01)

The effect of beta-blockers in acute heart failure according to heart rate
de réir: Hyun-Jin Kim, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Are beta-blockers effective in heart failure with preserved ejection fraction?
de réir: Javier Alegría, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Is carvedilol better than other beta-blockers for heart failure?
de réir: Carmen Rain, et al.
Foilsithe / Cruthaithe: (2015-06-01)

Poor tolerance of beta-blockers by elderly patients with heart failure
de réir: Satoshi Yanagisawa, et al.
Foilsithe / Cruthaithe: (2010-11-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
de réir: V. D. Zakiev, et al.
Foilsithe / Cruthaithe: (2023-12-01)

THE EFFECT OF BETA-BLOCKERS ON A COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH A NONTOXIC GOITER
de réir: Pyvovar S. M., et al.
Foilsithe / Cruthaithe: (2019-11-01)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
de réir: McMurray, J, et al.
Foilsithe / Cruthaithe: (2005)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
de réir: Valentina Carubelli, et al.
Foilsithe / Cruthaithe: (2021-06-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
de réir: S. N. Tereshchenko, et al.
Foilsithe / Cruthaithe: (2016-01-01)

The Effects of Beta-Blockers on Leukocytes and the Leukocyte Subpopulation in Heart Failure Patients
de réir: Anca Daniela Farcaş, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Predictors of Therapeutic Response to Beta-blockers in Patients with Heart Failure in Taiwan
de réir: Hsin Hu, et al.
Foilsithe / Cruthaithe: (2007-08-01)

Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure
de réir: Alberto Genovesi Ebert, et al.
Foilsithe / Cruthaithe: (2016-01-01)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1992)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1992)

Influence of left ventricular pressures and heart rate on myocardial high-energy phosphate metabolism.
de réir: Neubauer, S
Foilsithe / Cruthaithe: (1998)

Abnormal Cardiac High Energy Phosphate Metabolism and Impaired Diastolic Function after Mt Everest: A Reversible Model of Early Heart Failure?
de réir: Holloway, C, et al.
Foilsithe / Cruthaithe: (2008)

Changing beta-blockers in heart failure: when is a class not a class?
de réir: Aronson, J
Foilsithe / Cruthaithe: (2008)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
de réir: Pupalan Iyngkaran, et al.
Foilsithe / Cruthaithe: (2016-10-01)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
de réir: Pupalan Iyngkaran, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Hemodynamic and endotheliym-protective effects of beta-blockers in patients with chronic heart failure and atrial fibrillation ischemic origin
de réir: Aliara N. Zakirova, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
de réir: Yoshiaki Kubota, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers
de réir: Xue Geng, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
de réir: Kenneth D. Varian, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Nonselective beta‐blockers reduce mortality in patients with acute‐on‐chronic liver failure
de réir: Anand V. Kulkarni, et al.
Foilsithe / Cruthaithe: (2022-06-01)

THE INFLUENCE OF DIFFERENT BETA-BLOCKERS (ANAPRILIN, ATENOLOL, NEBILET) ON THE LEVEL OF 11-OXYCORTICOSTEROIDS IN RATS WITH EXPERIMENTAL CHRONIC HEART FAILURE
de réir: O. V. Smirnova, et al.
Foilsithe / Cruthaithe: (2002-02-01)